References
- Jalalat SZ, Cohen PR. Gefitinib-associated vitiligo: report in a man with parotid squamous cell carcinoma and review of drug-induced hypopigmentation. Dermatol Online J 2013;19:20020.
- Weetman A. Immune reconstitution syndrome and the thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:693-702. https://doi.org/10.1016/j.beem.2009.07.003
- Pollack BP, Sapkota B, Cartee TV. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clin Cancer Res 2011;17:4400-4413. https://doi.org/10.1158/1078-0432.CCR-10-3283
- Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr 2009;21:523-528. https://doi.org/10.1097/MOP.0b013e32832cf824
- Grani G, Dicorato P, Dainelli M, et al. Thyroid diseases in women with breast cancer. Clin Ter 2012;163:e401-e404.
Cited by
- Trastuzumab : Autoimmune thyroid disease: case report vol.1603, pp.1, 2016, https://doi.org/10.1007/s40278-016-18039-y
- Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC) vol.11, pp.9, 2016, https://doi.org/10.3390/cancers11091297